We use cookies to provide and improve our services. By using our site, you consent to cookies. OK Learn more about our privacy policy
Unfortunately, we do not answer medical questions.
Click on Apple, to verify that you are not a robot
Kathleen Schmeler MDGynecological OncologistMD Anderson Cancer CenterHouston, TexasOlesya Solheim MDGynecological OncologistOslo University HospitalNorway
The cause is unknown in most cases, but development of trophoblastic disease is observed in association with earlier occurrence of hydatidiform mole. The risk for a recurrent mole is 0.6–2%.
Oslo University Hospital shall not be liable for any loss whether direct, indirect, incidental or consequential, arising out of access to, use of, or reliance upon any of the content on this website. Oslo University Hospital© 2018